Ophthotech reported $16.11M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Alimera Sciences ALIM:US $ 9.81M 283K
Applied Genetic Technologies AGTC:US $ 4.84M 519K
Cytrx CYTR:US 51.91K 1.93M
Insmed INSM:US $ 59.97M 3.23M
Nektar Therapeutics NKTR:US $ 21.44M 5.9M
Novartis NOVN:VX 3.59B 91M
Ophthotech OPHT:US $ 16.11M 3.99M
Regeneron Pharmaceuticals REGN:US $ 476.3M 26.3M